16 DHC 2024

24 - 26 January 2024
Wednesday 24 January
Athene B/C (Dutch spoken)
09:30 - 10:30
Tips & Tricks Toxiciteits management Multipel Myeloom
Moderators:
Dr. Janine Van Elssen,
Drs. Elizabeth de Kort
09:30 - 10:00
Vreemde indringers: een indringend verhaal over hoe infecties te voorkomen en behandelen bij immunotherapie voor Multipel Myeloom
Speaker:
Prof. dr. Niels van de Donk
10:00 - 10:30
Release en functieverlies bij bispecifieke antistof en CAR-T cel therapie
Speaker:
Dr. Wifried Roeloffzen
Foyer 2
09:30 - 10:45
Myeloid Abstracts (1)
Moderator:
Dr. Emma de Pater
09:30 - 09:45
Neutrophil development in bone marrow follows a linear conveyor belt
Speaker:
N. Vrisekoop
09:45 - 10:00
iPSC disease models to study and treat Diamond-Blackfan Anemia Syndrome (DBAS)
Speaker:
C. Clark
10:00 - 10:15
Identification of blood-resident macrophages (bMΦ)
Speaker:
B. Weijts
10:15 - 10:30
Mutant SRSF2 in erythropoiesis
Speaker:
A. Marneth
10:30 - 10:45
The role of LZTR1 in hematopoietic malignancies
Speaker:
J. Bigenzahn
Room 4/5
09:30 - 10:30
Clinical Abstracts (1)
Moderator:
Dr. Hilde Kooistra
09:30 - 09:45
Comparison of two frailty indexes used in newly diagnosed multiple myeloma patients
Speaker:
K. Groen
09:45 - 10:00
Real-World Data (RWD) to supplement treatment arms of prospective phase III MM trials
Speaker:
A.J.T. Smit
10:00 - 10:15
Fracture Rate After Radiation Therapy to the Spine in Multiple Myeloma Patients
Speaker:
J.P. te Velde
10:15 - 10:30
Remineralization Rate of Lytic Bone Lesions in Multiple Myeloma Patients After Radiation
Speaker:
J.P. te Velde
Room 6/7
09:30 - 10:45
Immunology Abstracts (1)
Moderator:
Dr. Erfan Nur
09:30 - 09:45
1.1. Immunology Abstract
Speaker:
A.A. van de Loosdrecht
09:45 - 10:00
Decitabine pre-SCT decreases terminal CD8 T cells and promotes NK maturation post-SCT
Speaker:
D. van Ens
10:00 - 10:15
The ‘Stop TPO-receptor agonist in ITP Patients’ (STIP) study; a quest to unravel the immun
Speaker:
V.S. Nelson
10:15 - 10:30
Cryopreserved CAR-NK cells as off-the-shelf cancer therapy
Speaker:
L. Hooimaaijers
10:30 - 10:45
Long-lasting AML-specific antibody responses after allogeneic hematopoietic progenitor cel
Speaker:
R. Nahui Palomino
Foyer
10:30 - 11:00
Coffee/tea break
Athene B/C (Dutch spoken)
11:00 - 12:00
How to treat - AIHA
Moderator:
Dr. Josephine.M.I Vos

Moderator: 

11:00 - 11:05
Inleiding in Auto-Immuun Hemolytische Anemia (AIHA)
Speaker:
Dr. Josephine.M.I Vos
11:05 - 11:20
Warme AIHA: klinische aanpak en nieuwe ontwikkelingen
Speaker:
Dr. Liesbeth .E.M. Oosten
11:20 - 11:40
Koude AIHA: klinische aanpak en nieuwe ontwikkelingen
Speaker:
Dr. Sophie Bernelot-Moens
11:40 - 12:00
Transfusie bij AIHA: DAT positief, restrictief of liberaal
Speaker:
Prof. dr. Masja de Haas
Foyer 2 (Dutch spoken)
11:00 - 12:00
Geriatrische patienten en hematologische ziekten en behandelingen
Moderator:
Dr. Claudia Stege
11:00 - 11:30
Geriatrisch assessment door de hematoloog: hoe en waarom?
Speaker:
Dr. Josephine Stoffels
11:30 - 12:00
Fit to transplant
Speaker:
Dr. Rebecca Verheggen
Room 4/5
11:00 - 12:00
Clinical Abstracts (2)
Moderator:
Dr. Vera Novotny
11:00 - 11:15
Prospective Clinical Studies in Patients with Hematological Malignancies using Real-World-
Speaker:
N.G. van der Maas
11:15 - 11:30
Mucositis-associated bloodstream infections
Speaker:
N. de Jonge
11:30 - 11:45
COVID-19 Vaccine T Cell Responses in Patients with Hematologic Malignancies
Speaker:
Q. Hofsink
11:45 - 12:00
SARS-CoV-2 mRNA Vaccination in Patients with Sickle Cell Disease on Hydroxyurea
Speaker:
S. Haggenburg
Room 6/7
11:00 - 12:15
Immunology Abstracts (2)
11:00 - 11:15
T cells from CLL patients are not exhausted but show signs of senescence
Speaker:
E. Camerini
11:15 - 11:30
Soluble GPI-anchored complement regulators in PNH
Speaker:
E. de Boer
11:30 - 11:45
Functional characterization of high yield clinical grade expanded NK cells and their poten
Speaker:
C.H.M.J. Van Elssen
11:45 - 12:00
T cell lipid metabolism is disturbed in CLL
Speaker:
C. Jacobs
12:00 - 12:15
Imaging of the bone marrow in aplastic anemia
Speaker:
E. Pool
Room 8/9
11:00 - 12:00
Myeloid Abstracts (2)
Moderators:
Dr. Bert van der Reijden,
Dr. Carolien Woolthuis
11:00 - 11:15
Mapping AML heterogeneity - transcriptomic analysis identifies novel subtypes
Speaker:
J. Severens
11:15 - 11:30
Immunophenotypic profiles in AML have distinct prognostic value and treatment resistance
Speaker:
N. van der Meer
11:30 - 11:45
Leveraging single-cell multiomic sequencing to dissect intratumor heterogeneity across AML
Speaker:
R. Thijssen
11:45 - 12:00
Induced differentiation of pediatric acute myeloid leukemia blasts
Speaker:
P. Derevianko
Room 14 (Dutch spoken)
12:15 - 13:00
Meet the expert (1)
12:15 - 13:00
VEXAS en andere immuun fenomenen
Speakers:
Dr. Karin Mulders-Manders,
Dr. Bram Rutgers
Room 2 (Dutch spoken)
12:15 - 13:00
Meet the expert (2)
12:15 - 13:00
De neurologische kenmerken van LPL cellen en het IGM M-proteine; relatie, associatie of co incidentie?
Speaker:
Prof. dr. Monique Minnema
Room 3 (Dutch spoken)
12:15 - 13:00
Meet the expert (3)
12:15 - 13:00
Curatieve therapieën (inclusief gentherapie) bji Sikkelcelziekte
Speakers:
Dr. Emiel van den Akker,
Dr. Erfan Nur
Room 4/5 (Dutch spoken)
12:15 - 13:00
Meet the expert (4)
12:15 - 13:00
Risico scores: onmisbaar of misleidend?
Speaker:
Dr. Jurjen Versluis
Room 6/7
12:15 - 13:00
Meet the expert (6)
12:15 - 13:00
Ex vivo bone marrow cultures
Speakers:
Dr. Richard Groen,
Dr. Zsolt Sebestyen
Sydney
13:00 - 13:45
Lunch in Sydney
Sydney
13:45 - 14:15
After lunch theme session in Sydney
Athene B/C (Dutch spoken)
14:15 - 15:45
Educational - AML
Moderators:
Prof. dr. Gerwin Huls,
Prof. dr. Marc Raaijmakers
14:15 - 14:45
AML en genetische predispositie: TBD
Speaker:
Dr. Anna Aalbers
14:45 - 15:15
FLT3 gemuteerde AML: TBD
Speaker:
Dr. Dave de Leeuw
15:15 - 15:45
MRD en behandelbeslissingen (voor en na transplantatie): TBD
Speaker:
Drs. Linde Morsink
Foyer 2
14:15 - 15:45
Immunology Abstracts (3)
14:15 - 14:30
Dual Split-Signaling CAR T-Cells Targeting CLEC12a+TIM3 as a therapy for AML
Speaker:
J. van der Schans
14:30 - 14:45
TP53 loss Impairs DR Expression and protects BCP-ALL from CD19-directed CAR T-Cell Therapy
Speaker:
N.M.M. Dautzenberg
14:45 - 15:00
Installing dual-antigen-specificity on T-cells through combined CAR and TCR engineering
Speaker:
T.L.A. Wachsmann
15:00 - 15:15
Novel K12 ligand-based CAR T cell therapy for CD7-positive T-cell malignancies
Speaker:
N. Visser
15:15 - 15:30
Long-lived early memory CAR T cells to improve clinical efficacy
Speaker:
A. van der Waart
15:30 - 15:45
Preclinical activity of UCARTCS1 in Multiple Myeloma
Speaker:
C. Korst
Room 4/5
14:15 - 15:30
Clinical Abstracts (3)
Moderator:
Dr. Roel Fiets
14:15 - 14:30
Autologous hematopoietic stem cell transplantation for MS
Speaker:
E. Kramer
14:30 - 14:45
Alphabeta T-cell/CD19 depleted allo-SCT with post-transplant ruxolitinib for myelofibrosis
Speaker:
F. G. Weverling
14:45 - 15:00
Allogeneic stem cell transplantation for adults with inborn errors of immunity
Speaker:
A.L. Kreuger
15:00 - 15:15
αβT/CD19 Cell Depleted Allo-HCST in Adults with Non-malignant Hematological Conditions
Speaker:
J. de Winter
15:15 - 15:30
Evaluation of upfront allogeneic stem cell transplantation for acquired aplastic anemia
Speaker:
I.N. Lommerse
Room 6/7
14:15 - 15:45
Lymphoid Abstracts (1)
Moderator:
Dr. Fleur de Groot
14:15 - 14:30
Unveiling clonal evolution: follicular lymphoma
Speaker:
E. Hesius
14:30 - 14:45
NGS-based clonality detection: Applications in hematopathology.
Speaker:
P. Groenen
14:45 - 15:00
AID skews DLBCL subtype and the oxygen-mediated regulation of AID in lymphoma
Speaker:
T. van Dam
15:00 - 15:15
Dysregulated snoRNA expression in B-cell precursor ALL
Speaker:
M. Verbeek
15:15 - 15:30
1.5 Lymphoid abstract
15:30 - 15:45
1.6. Lymphoid abstract
Room 8/9 (Dutch spoken)
14:15 - 15:45
Masterclass Beenmerg diagnostiek (deel 1 van 2)
Speakers:
Dr. Ellen Kuiper,
Dr. Wendy Stevens,
Dr. Marielle Wondergem
Foyer
15:45 - 16:15
Coffee/tea break
Athene B/C (Dutch spoken)
16:15 - 17:45
Educational - Stamceltransplantatie
Moderator:
Dr. Michel Schaap

Sprekers: Drs. Linde Morsink, Dr. Moniek de Witte, Dr. Mieke Roeven, Dr. Annoek Broers

16:15 - 17:00
Betere overleving na allogene stamceltransplantatie: succesvolle ontwikkelingen uit het afgelopen decennium en mogelijkheden voor de toekomst
17:00 - 17:45
Relapse na allogene stamceltransplantatie: mogelijkheden voor preventie en behandeling
Foyer 2
16:15 - 17:45
Lymphoid Abstracts (2)
Moderator:
Dr. Janine Van Elssen
16:15 - 16:30
CD38 targeting in Multiple Myeloma
Speaker:
A. Abel Gutierrez
16:30 - 16:45
Loss-of-adhesion CRISPR screen identifies GRK6 as a potential therapeutic target in Multip
Speaker:
F. Ma
16:45 - 17:00
Unraveling ER stress induced cell death in B cell malignancies by CRISPR screens
Speaker:
D. Both
17:00 - 17:15
Early cHL relapse detection with routine serum TARC measurements
Speaker:
S. Teesink
17:15 - 17:30
Engineering BCMA CAR T cells for myeloma-targeted cargo delivery
Speaker:
T. Kimman
17:30 - 17:45
Novel insights into TKI sensitivity in BCR::ABL1-positive and ABL-class ALL
Speaker:
I. van Outersterp
Room 4/5
16:15 - 17:45
Clinical Abstracts (4)
16:15 - 16:30
Survival of children vs. AYAs with NHL subtypes in the Netherlands
Speaker:
M. Schulpen
16:30 - 16:45
Comparison of 6xR-CHOP21 versus 6xR-CHOP21+2R for advanced-stage DLBCL
Speaker:
C. Maas
16:45 - 17:00
Impact of CNS prophylaxis on CNS relapse in DLBCL patients
Speaker:
D. Al-Sarayfi
17:00 - 17:15
Impact of vincristine dose intensity on overall survival in patients with DLBCL treated wi
Speaker:
J. Kortleve
17:15 - 17:30
Causes of death in CLL
Speaker:
L. van der Straten
17:30 - 17:45
Quality of life in chronic lymphocytic leukemia patients treated with venetoclax+ibrutinib
Speaker:
L. Eurelings
Room 6/7
16:15 - 17:45
Myeloid Abstracts (3)
Moderators:
Dr. Vincent van den Boom,
Dr. Carlijn Voermans
16:15 - 16:30
The homeobox transcription factor HMX3 drives pediatric KMT2A::MLLT3 AML
Speaker:
L. van Hoof
16:30 - 16:45
LSD1/KDM1A and GFI1B control iPSC-derived EHT.
Speaker:
H. Zhang
16:45 - 17:00
PRC1.1 loss-of-function transcriptional dynamics are wired in the epigenetic ground state
Speaker:
F. Mojallali
17:00 - 17:15
Targeting super-enhancers driving EVI1 expression in leukemia by inhibition of p300/CBP
Speaker:
D. Pastoors
17:15 - 17:30
Effect of RUNX1 mutations on gene transcription and immune response
Speaker:
M. Gerritsen
17:30 - 17:45
Identification of targeted therapies for AML MRD
Speaker:
N. van Gils
Room 8/9 (Dutch spoken)
16:15 - 17:45
Masterclass Beenmerg diagnostiek (deel 2)


NB: deel 2 van de masterclass kan alleen worden gevolgd met een registratie voor deel 1.

Foyer
17:45 - 18:15
Net work drinks
Athene B/C
18:15 - 19:15
Keynote lecture: Insights into molecular medicine from the analysis of a single locus

Keynote speaker: Douglas Higgs FRS
Moderator: Dr. Vincent van den Boom

Foyer
19:00 - 20:00
Buffet
Athene A (Dutch spoken)
09:00 - 10:30
Educational -Nieuwe richtlijn T- cell Lymfoom
Moderator:
Dr. Joost Vermaat
09:00 - 09:30
Nieuwe WHO/ICC classificatie voor T-cellymfomen
Speaker:
Dr. Lorraine de Haan
09:30 - 10:00
Diagnostiek en 1e lijn behandeling
Speaker:
Dr. Marjolein van der Poel
10:00 - 10:30
2e lijn behandeling en meer
Speaker:
Dr. Marcel Nijland
Athene B/C (Dutch spoken)
09:00 - 10:30
Educational CLL

Moderator en sprekers: 
Prof. dr. Arnon Kater, dr. Mark David Levin, dr. Doreen te Raa, dr. Ellen van der Spek, Rogier Mous, Sabina Kersting, Marjolein van der Klift.

 

09:00 - 09:30
Casuistiek eerste lijn
09:30 - 10:00
Casuistiek recidief setting
10:00 - 10:30
Welke vragen liggen er voor CLL: nieuwe studies
Room 4/5
09:00 - 10:30
Clinical abstracts (5)
Moderators:
Dr. Canan Alhan,
Dr. Sarah Schep
09:00 - 09:15
AML Patients of the HARMONY Alliance and H103 Control Patients Have Comparable Outcome
Speaker:
S. Hermans
09:15 - 09:30
A Novel Prognostic Model for Patients with Acute Myeloid Leukemia in First Relapse
Speaker:
N.G. van der Maas
09:30 - 09:45
Venetoclax-HMA as a bridge towards allogeneic HSCT or DLI in R/R AML
Speaker:
K. Verdeyen
09:45 - 10:00
Early detection of MPN using artificial intelligence trained algorithms
Speaker:
P.E. Westerweel
10:00 - 10:15
TFR prediction with BCR::ABL1 dPCR
Speaker:
C. Kockerols
10:15 - 10:30
BCR::ABL1 dPCR as a TFR prediction tool
Speaker:
C. Kockerols
Room 6/7 (Dutch spoken)
09:00 - 10:30
Educational Stolling: Bloedingsziekten
Moderator:
Dr. Anja Mäkelburg
09:00 - 09:30
Verworven hemofilie, van diagnose tot behandeling; nieuwe landelijke richtlijn
Speaker:
Prof. dr. Jeroen Eikenboom
09:30 - 10:00
Gentherapie voor hemofilie; een update
Speaker:
Prof. dr. Frank Leebeek
10:00 - 10:30
Verworven Ziekte van Von Willebrand; nieuwe landelijke richtlijn
Speaker:
Dr. Laurens Nieuwenhuizen
Room 8/9
09:00 - 10:30
Immunology Abstracts (4)
Moderators:
Dr. Peter van Balen,
Dr. Annoek Broers
09:00 - 09:15
Plasma proteomics predicting SR-GvHD
Speaker:
C. de Koning
09:15 - 09:30
Barcoded multimers to measure T-cell frequencies against minor histocompatibility antigens
Speaker:
K.J. Fuchs
09:30 - 09:45
Immune responses after CMV reactivation in αβT cell depleted allo-SCT recipients
Speaker:
A. Stuut
09:45 - 10:00
Proteomic profiling of allogeneic hematopoietic stem cell transplantation recipients
Speaker:
M. Verheij
10:00 - 10:15
Increased anti-HLA antibodies after 2 SARS-CoV-2 vaccination
Speaker:
L.S. Boerenkamp
10:15 - 10:30
Model-based dosing of anti-thymocyte globulin in pediatric HCT
Speaker:
R. Admiraal
Foyer
10:30 - 11:00
Coffee / tea break
Athene A (Dutch spoken)
11:00 - 12:30
Tips & Tricks: ALL:
Moderators:
Dr. Stijn Halkes,
Drs. Danielle van Lammeren
11:00 - 11:30
Diagnostische stappen te nemen bij een ALL: anno 2023
Speaker:
Dr. Lotte van der Wagen
11:30 - 12:00
Lastige behandeling door multi-drug kuren: tips
Speaker:
Dr. Geerte van Sluis
12:00 - 12:30
HOVON studies en ALL een update en een perspectief
Speaker:
Dr. Anita Rijneveld
Athene B/C (Dutch spoken)
11:00 - 12:30
Educational beschikbaarheid van geneesmiddelen
Moderator:
Dr. Fleur Kleijwegt
11:00 - 11:30
Mag ik het nu voorschrijven? Nieuwe geneesmiddelen: van studie tot toepassing in de praktijk
Speaker:
Dr. Rogier Mous
11:30 - 12:00
Geneesmiddelschaarste, waarom en wat te doen?
Speaker:
Dr. Jan Dietert Brugma
12:00 - 12:30
De rol van de hematoloog
Speaker:
Prof. dr. Karina Meijer
Room 4/5
11:00 - 12:30
Lymphoid Abstracts (3)
Moderators:
Prof. dr. Arnon Kater,
Dr. Roel Klein Wollterink
11:00 - 11:15
Glutamine addiction in the CLL microenvironment
Speaker:
H. Simon-Molas
11:15 - 11:30
Treatment with obinutuzumab and venetoclax reshapes the TRB repertoire of CLL patients
Speaker:
T. Langerak
11:30 - 11:45
Richter syndrome in subset #8 CLL
Speaker:
L. van der Straten
11:45 - 12:00
Genomic Profiling of B-Cell Lymphomas Using Liquid Biopsies
Speaker:
N. Veltmaat
12:00 - 12:15
Clonal Architecture of Monoclonal B Lymphocytosis
Speaker:
C.A.M. van Bergen
12:15 - 12:30
Cell-free DNA for Outcome Prediction in Lymphoma
Speaker:
J. Wang
Room 6/7 (Dutch spoken)
11:00 - 11:45
Meet the expert (5)
11:00 - 11:45
Afwijkende NIPT
Speaker:
Dr. Saskia Langemeijer

Duration: 45 minutes

Room 8/9
11:00 - 12:30
Myeloid abstracts (4)
11:00 - 11:15
Blood organoids from induced pluripotent stem cells: generating hematopoietic stem cells
Speaker:
L. Dijkhuis
11:15 - 11:30
Generation of human ILC3 from CD34+ hematopoietic progenitors for adoptive transfer
Speaker:
M. Verheij
11:30 - 11:45
Dissecting the carcinogenic potential of hematopoietic stem cell differentiation
Speaker:
S. Middelkamp
11:45 - 12:00
Clonal hematopoiesis in long-term survivors of pediatric stem cell transplantation
Speaker:
K. Müskens
12:00 - 12:15
Amino acid essentiality in Acute Myeloid Leukemia
Speaker:
L. Oudejans
12:15 - 12:30
Computational assessment of measurable residual disease in acute myeloid leukemia
Speaker:
T. Mocking
Foyer
12:30 - 13:30
Lunch
Sydney
13:30 - 14:00
After lunch theme session in Sydney
Athene B/C
14:00 - 15:00
Keynote Lecture :"Targeted combination therapy: a way to long-term remissions in chronic lymphocytic leukemia

Keynote speaker: Prof. dr. med. Barbara Eichhorst
moderator: dr. Sabina Kersting

Athene A (Dutch spoken)
15:00 - 16:30
How to treat - Myelofibrose
Moderator:
Dr. Peter te Boekhorst
15:00 - 15:30
Overzicht diagnostiek en therapie
Speaker:
Dr. Mels Hoogendoorn
15:30 - 16:00
PMF en allogene stamceltransplantatie
Speaker:
Dr. Michel Schaap
16:00 - 16:30
Nieuwe middelen bij de behandeling van PMF
Speaker:
Dr. Moniek de Witte
Athene B/C (Dutch spoken)
15:00 - 16:30
Educational CAR-T cel therapie
Moderators:
Dr. Suzanne van Dorp,
Dr. Ilse Kuipers
15:00 - 15:30
CAR T-cel bij de oudere patient
Speaker:
Dr. Marjolein van der Poel
15:30 - 16:00
Point of care CAR-T celproductie: ervaringen in de HOVON161 trial
Speaker:
Dr. Tom van Meerten
16:00 - 16:30
CAR T-cel therapie bij ALL
Speaker:
Dr. Lotte van der Wagen
Room 4/5
15:00 - 16:30
Clinical abstracts (6)
Moderator:
Dr. Laurens Nieuwenhuizen
15:00 - 15:15
Plasma Proteome Profiling of SCD Patients During Steady State and VOC
Speaker:
L. de Ligt
15:15 - 15:30
The effect of voxelotor on erythrocyte deformability, neutrophil phenotype and endothelial
Speaker:
K. Konte
15:30 - 15:45
The effects of HSCT on SCD-related organ complications
Speaker:
E. Dovern
15:45 - 16:00
Biomarkers in Hereditary Spherocytosis
Speaker:
J. de Wilde
16:00 - 16:15
Basic clinical parameters as predictor of bleeding in thrombocytopenic hematology patients
Speaker:
B. Batman
16:15 - 16:30
Clinical value of laboratory diagnostics for bleeding disorders in general practice
Speaker:
A. Monard
Room 6/7
15:00 - 16:30
Benigne Abstracts
Moderators:
Drs. Sophie Hordijk,
Dr. Joline Saes
15:00 - 15:15
Innovative laboratory tests in a family with dysfibrinogenemia
Speaker:
A. Monard
15:15 - 15:30
Cross-reactivity in antiphospholipid syndrome
Speaker:
D. van Mourik
15:30 - 15:45
HMB-001 - A bispecific antibody for prophylactic treatment of bleeding disorders
Speaker:
M. Zivkovic
15:45 - 16:00
Comparative analysis of thrombin generation platforms for patients with bleeding disorders
Speaker:
B. Haisma
16:00 - 16:15
Personalized gene therapy development for VWD patients
Speaker:
I. Bär
16:15 - 16:30
Proteomic screening in Bleeding Disorders of Unknown Cause
Speaker:
T. van Duijl
Room 8/9
15:00 - 16:30
Top of DHC - Best of ASH
Moderators:
Prof. dr. Erik Beckers,
Prof. dr. Marie José Kersten
15:00 - 15:15
Safety and efficacy of TEG001
Speaker:
M. de Witte
15:15 - 15:30
10-day decitabine versus 3+7 chemotherapy followed by allografting in older AML patients
Speaker:
G. Huls
15:30 - 15:45
Risk of Severe SARS-CoV-2 Infections in COVID-19 Vaccinated Individuals with Hematologic M
Speaker:
Q. Hofsink
15:45 - 16:00
Pacritinib before RIC allogeneic stem cell transplantation in myelofibrosis
Speaker:
R. van Dijck
16:00 - 16:15
Dynamic frailty status enables better prediction of survival probability
Speaker:
F. Smits
16:15 - 16:30
Evolutionary landscape of clonal hematopoiesis
Speaker:
I. van Zeventer
Foyer
16:30 - 17:00
Coffee / tea break
Athene B/C (Dutch spoken)
17:00 - 17:20
Genomineerde Jaap Steenbergen Stipendium: uitreiking en presentatie
Athene B/C (Dutch spoken)
17:20 - 17:45
Genomineerde Swammerdam: uitreiking en presentatie
Athene B/C (Dutch spoken)
17:45 - 18:45
Keynote speaker: Dr. Esther van Fenema: Ken u zelve zodat je een betere versie van jezelf kunt worden!

Moderator: Dr. Suzanne van Dorp

Foyer
18:45 - 20:30
Buffet
Centre Court
20:31 - 23:59
Social Program
Athene A (Dutch spoken)
09:00 - 10:30
Educational Essentiele trombocytose
Moderator:
Dr. Peter te Boekhorst
09:00 - 09:30
Overzicht diagnostiek en therapie ET
Speaker:
Dr. Sabina Kersting
09:30 - 10:00
Behandeling van ET: Gepegyleerd interferon versus hydroxycarbamide
Speaker:
Dr. Marielle Wondergem
10:00 - 10:30
Toekomstige ontwikkelingen
Speaker:
Dr. Manu Ammatuna
Athene B/C (Dutch spoken)
09:00 - 10:30
Educational Multipel Myeloom
Moderators:
Dr. Marjolein van der Klift,
Dr. Inger Nijhof
09:00 - 09:30
Wat te doen als er wel betekenis is of als het smeult-nieuws over MGSC en SMM
Speakers:
Dr. Annemiek Broyl,
Prof. dr. Monique Minnema
09:30 - 10:00
Niet refractair voor triple-refractair- hoe te behandelen als veel niet werkt
Speakers:
Dr. Rimke Oostvogels,
Dr. Paula Ypma
10:00 - 10:30
Fabulous studies in het vizier - (MRD-gebaseerd) stoppen?
Speakers:
Dr. Hans Jacobs,
Prof. dr. Sonja Zweegman
Foyer 2 (Dutch spoken)
09:00 - 10:30
Educational Stolling : Trombose en antistolling
Moderator:
Dr. Sarah Schep
09:00 - 09:30
Lijngerelateerde trombose en geinfecteere trombi; best practice
Speakers:
Dr. Saskia Kuipers,
Dr. Mandy Lauw
09:30 - 10:30
Trombofilie: wanneer testen en bij wie? Nieuwe ASH richtlijnen en ALIFE2 studie resultaten
Speaker:
Prof. dr. Saskia Middeldorp
10:00 - 10:30
Couperen van antistolling: wat kan, wat is nieuw en wat is wijsheid?
Speaker:
Prof. dr. Karina Meijer
Foyer
10:30 - 11:00
Koffie / Thee pauze
Sydney
11:00 - 11:30
Thema sessie na de koffie in de Sydney
Athene A (Dutch spoken)
11:30 - 13:00
Gezamenlijke sessie: HOVON-NVvH en patienten verenigingen;

IZA regionalisatie: Een levendige discussie tussen beroepsbeoefenaren en patienten

Athene B/C (Dutch spoken)
11:30 - 13:00
Educational Diffuus grootcellig B cel lymfoom
Moderators:
Dr. Martine Chamuleau ,
Dr. Marjolein van der Poel
11:30 - 12:00
De rol van PET CT en radiomics bij DLBCL
Speaker:
Prof. dr. Josée Zijlstra
12:00 - 12:30
Behandelopties R/R DLBCL in de 2e lijn-huidige praktijk en toekomst
Speaker:
Dr. Pim Mutsaers
12:30 - 13:00
CZS profylaxe bij DLBCL: intrathecaal, intraveneus of helemaal niet?
Speaker:
Dr. Margot Jak
Foyer 2 (Dutch spoken)
11:30 - 13:00
Symposium Vereniging Hematologisch Laboratorium
Moderator:
Dr. M.V. Lukens
11:30 - 12:15
Analyse bloedingsneiging vanuit klinisch perspectief
Speaker:
Dr. Floor Heubel-Moenen
12:15 - 13:00
Analyse bloedingsneiging vanuit laboratoriumperspectief
Speaker:
Dr. Yvonne Henskens
Dummy
13:00 - 14:00
Lunch in Sydney
Dummy
13:01 - 14:00
Algemene Leden Vergadering NVvH (incl. lunch)
Dummy
13:02 - 14:00
Algemene ledenvergadering JNVvh
Athene B/C (Dutch spoken)
14:00 - 15:00
Grand Round

Moderatoren: dr. Inge Geelen en dr. Sophie van Benthum
Casuistiek met expert panel

Panel speaker: Dr. Goda Choi, dr. Laurens Nieuwenhuizen, drs. Lucas Falke

Register
×